The global genotyping market is expected to grow with the CAGR of 20%-25% by 2025


   January 13, 2021
According to a new market report published by Lucintel, the future of the genotyping market looks promising with opportunities in diagnostics, drug discovery personalized medicine, academic research, and agriculture applications. The global genotyping market is expected to grow with a CAGR of 20%-25% from 2020 to 2025. The major drivers for this market are increasing research and development activities in the healthcare sector, rising prevalence of genetic diseases, and technological advancement in gene studies.

Genotyping is the process to understand the genetic structure of any living organisms, such as humans, animals, plants, and microorganisms. In this market, reagents and kits, instruments, and services are the major product types. Lucintel forecasts that reagents and kits will remain the largest product segment over the forecast period due to a wide usage rate, surging demand for genotyping tests, cost-effectiveness, and easy availability of reagents.

Within this market, personalized medicine will remain the largest application segment over the forecast period due to rising government support for personalized medicine, changing reimbursement and regulatory landscape, and the growing adoption of sequencing for genetic mapping.

North America will remain the largest region over the forecast period due to the well-established healthcare infrastructure and rapid advancements in technology in the region.

QIAGEN, Affymetrix, Illumina, Thermo Fisher Scientific, General Electric, Agilent Technologies, and Roche are among the major suppliers in the global genotyping market.

Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global genotyping market by product, technology, application, end user, and region. Lucintel has prepared a comprehensive research report titled “Growth Opportunities in the Global Genotyping Market 2020-2025: Trends, Forecast, and Opportunity Analysis.” This Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global genotyping market by product, technology, application, end user, and region as follows:

By Product [Value ($ Million) shipment analysis for 2014 – 2025]:



  • Reagents and Kits


  • Instruments


  • Services


By Technology [Value ($ Million) shipment analysis for 2014 – 2025]:



  • PCR (Polymerase Chain Reaction)


  • Capillary Electrophoresis


  • Mass Spectrometry


  • Sequencing


  • Microarray


  • Others


By Application [Value ($ Million) shipment analysis for 2014 – 2025]:



  • Diagnostics


  • Drug Discovery and Development


  • Personalized Medicine


  • Academic Research


  • Agricultural Biotechnology and Others


By End User [Value ($ Million) shipment analysis for 2014 – 2025]:



  • Pharmaceutical & Biopharmaceutical Companies


  • Diagnostic & Research Laboratories


  • Academic Institutes


  • Other End Users


By Region [Value ($ Million) shipment analysis for 2014 – 2025]:



  • North America




  • United States


  • Canada


  • Mexico




  • Europe




  • United Kingdom


  • Spain


  • Germany


  • France




  • Asia Pacific




  • China


  • India


  • Japan




  • The Rest of the World




  • Brazil


 

This more than 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or visit us at helpdesk@lucintel.com.

About Lucintel

Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision makers in a variety of industries. For further information, visit www.lucintel.com.

Lucintel Corporate Customers

Market Entry, M & A, Opportunity Screening,...

Private Equity Customers

Buy Side Services (target screening, due diligence, ..)

Customer Quotes

"With more than 20 years experience in the industry, this is the first time we have come across such an extensive market analysis for our industry." Ven Cote, CEO, ZCL

"The insights we gained from Lucintel work helped with our business plan…a wonderful professional job…" Mike Jackson, Stahlin

"The report from Lucintel is useful not only for business planners, but also for the technology officers wanting to create a roadmap …" Dr. Giulio Ranzo, Booz Allen

"The information is so comprehensive, it has allowed us to identify & focus our business development efforts. It saved months of leg-work." Bill Barz, L&L Products

"We bought Lucintel report because it is the best report about our industry…a complete and appropriate analysis." Cesare Andrenacci, Ferretti